Assessment of intraocular pressure changes following intravitreal injections of three anti-VEGF agents
Authors:
Open Access
- 16 March 2024
- journal article
- research article
- Published by Elsevier in AJO International
- Vol. 1 (1)
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Intraocular Pressure–Related Events After Anti–Vascular Endothelial Growth Factor Therapy for Macular Edema Due to Central Retinal Vein Occlusion or Hemiretinal Vein OcclusionJAMA Ophthalmology, 2021
- Intraocular pressure and injection forces during intravitreal injection into enucleated porcine eyesEuropean Journal of Pharmaceutics and Biopharmaceutics, 2021
- Intravitreal injections: past trends and future projections within a UK tertiary hospitalEye, 2021
- Risk of Systemic Adverse Events after Intravitreal Bevacizumab, Ranibizumab, and Aflibercept in Routine Clinical PracticeOphthalmology, 2021
- The Effect of Anti-Vascular Endothelial Growth Factor Agents on Intraocular Pressure and GlaucomaOphthalmology, 2019
- The acute and chronic effects of intravitreal anti-vascular endothelial growth factor injections on intraocular pressure: A reviewSurvey of Ophthalmology, 2018
- Adverse events and complications associated with intravitreal injection of anti-VEGF agents: a review of literatureEye, 2013
- Effect on Intraocular Pressure in Patients Receiving Unilateral Intravitreal Anti-Vascular Endothelial Growth Factor InjectionsOphthalmology, 2012
- Use of Retinal Procedures in Medicare Beneficiaries From 1997 to 2007Archives of Ophthalmology (1950), 2010
- Comparison of the ICare® rebound tonometer with the Goldmann applanation tonometer by experienced and inexperienced tonometristsEye, 2006